Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic

The SARS-CoV-2 coronavirus (COVID-19) pandemic has significantly impacted the delivery of cellular therapeutics, including chimeric antigen receptor (CAR) T cells. This impact has extended beyond patient care to include logistics, administration, and distribution of increasingly limited health care...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Bachanova, Veronika, Bishop, Michael R., Dahi, Parastoo, Dholaria, Bhagirathbhai, Grupp, Stephan A., Hayes-Lattin, Brandon, Janakiram, Murali, Maziarz, Richard T., McGuirk, Joseph P., Nastoupil, Loretta J., Oluwole, Olalekan O., Perales, Miguel-Angel, Porter, David L., Riedell, Peter A.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. 2020
Assuntos:
Position Statement
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7194685/
https://ncbi.nlm.nih.gov/pubmed/32298807
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2020.04.008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados